A new technique of treating leukemia using a patient’s own immune system which is being called a ‘living drug’ has worked in 88 percent of adults a team of researchers in the US has found.
Scientists in New York published a report in Science Magazine in December 2013, hailing the treatment as a breakthrough in the field of cancer immunotherapy, AFP reports.
The latest trial, which was published in the journal Science Translational Medicine, involved 16 people with adult B acute Lymphoblastic leukemia (ALL).
A 'living drug' from your immune system fights and wins against leukemia 88% of the time
